DA

Dopamine

Hormones

What is Dopamine?

Dopamine is a catecholamine that functions both as a neurotransmitter in the brain and as a hormone/paracrine signaling molecule in the periphery. In the brain, dopamine is critical for reward, motivation, motor control, executive function, and emotional regulation. Peripherally, dopamine is produced in the adrenal medulla, sympathetic neurons, and specialized cells in the gut and kidneys. Peripheral dopamine acts as a local vasodilator in the renal and mesenteric circulation and inhibits prolactin release from the pituitary.

Clinically, plasma and urinary dopamine measurements are primarily used in the evaluation of catecholamine-producing tumors (pheochromocytoma and paraganglioma). Dopamine is synthesized from the amino acid tyrosine through two steps: tyrosine hydroxylase converts tyrosine to L-DOPA, and DOPA decarboxylase converts L-DOPA to dopamine. Dopamine can be further converted to norepinephrine and then epinephrine. Dopamine is metabolized to homovanillic acid (HVA) by the enzymes COMT and MAO. Both fractionated catecholamines and their metabolites (metanephrines) are measured in tumor workups.

Why It Matters

Dopamine measurement is clinically important in the diagnosis of catecholamine-secreting tumors. Pheochromocytomas and paragangliomas that predominantly secrete dopamine are rare but can present atypically without the classic hypertension seen with norepinephrine/epinephrine-secreting tumors. Dopamine-secreting tumors are more likely to be malignant, extra-adrenal, and associated with hereditary syndromes (SDHB mutations). Plasma free metanephrines (including methoxytyramine, the O-methylated metabolite of dopamine) are the recommended first-line screening test for these tumors.

Normal Reference Ranges

GroupRangeUnit
Plasma Dopamine (supine)<30pg/mL
24-hour Urine Dopamine52–480µg/24h

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High DA Levels Mean

Common Causes

  • Pheochromocytoma or paraganglioma (dopamine-secreting)
  • Neuroblastoma (primarily in children)
  • Ganglioneuroma
  • Stress, exercise, or pain (transient physiological elevation)
  • Certain medications (levodopa, dopamine agonists)
  • Carcinoid tumors (occasionally)

Possible Symptoms

  • Hypertension (episodic or sustained, though some dopamine-secreting tumors cause hypotension)
  • Palpitations and tachycardia
  • Headaches
  • Sweating and flushing
  • Nausea and vomiting
  • Anxiety and panic-like episodes
  • Orthostatic hypotension (dopamine-dominant tumors)

What to do: Elevated catecholamines should prompt measurement of plasma free metanephrines (normetanephrine, metanephrine, and methoxytyramine) and/or 24-hour urinary fractionated metanephrines—these metabolites are produced continuously by tumor tissue and are more sensitive than episodic catecholamine levels. If biochemically confirmed, imaging with CT or MRI is performed for localization. MIBG scintigraphy or 68Ga-DOTATATE PET/CT may be needed for extra-adrenal, metastatic, or occult tumors. Genetic testing is recommended for all pheochromocytoma/paraganglioma patients, as up to 40% have hereditary mutations (RET, VHL, SDHx). Pre-operative alpha-blockade (phenoxybenzamine or doxazosin) is mandatory before surgical resection to prevent hypertensive crisis.

What Low DA Levels Mean

Common Causes

  • Parkinson's disease (central dopamine depletion)
  • Dopamine beta-hydroxylase deficiency (rare genetic disorder)
  • Autonomic neuropathy
  • Medications that deplete dopamine (reserpine, tetrabenazine)
  • Depression (associated with reduced dopaminergic tone)

Possible Symptoms

  • Motor symptoms: bradykinesia, rigidity, tremor (Parkinson's)
  • Fatigue and apathy
  • Difficulty with motivation and concentration
  • Low mood and anhedonia
  • Orthostatic hypotension (in dopamine beta-hydroxylase deficiency)

What to do: Peripheral dopamine levels do not reliably reflect central nervous system dopamine, so plasma/urine dopamine is not used to diagnose Parkinson's disease or psychiatric conditions. Parkinson's is diagnosed clinically and confirmed with dopamine transporter (DaT) scan imaging. Low peripheral dopamine in the context of severe orthostatic hypotension may suggest dopamine beta-hydroxylase deficiency, a rare genetic condition treated with droxidopa. For motivational and mood symptoms, evaluation by psychiatry or neurology is appropriate, and treatment targets the underlying condition.

When Is DA Testing Recommended?

  • When evaluating suspected pheochromocytoma or paraganglioma
  • When investigating neuroblastoma in children
  • When hypertension is accompanied by episodic symptoms (headache, sweating, palpitations)
  • When a family history of hereditary paraganglioma syndrome is present

Frequently Asked Questions

No. Peripheral dopamine measurements (blood or urine) do not reflect brain dopamine levels. Dopamine does not cross the blood-brain barrier, so plasma dopamine comes from the adrenal medulla, sympathetic neurons, and the gut—completely separate from brain dopamine pathways. Brain dopamine function is assessed through clinical evaluation (motor symptoms, cognitive function), specialized imaging (dopamine transporter DaT-SPECT scan for Parkinson's disease), and response to dopaminergic medications. There is currently no simple blood test that measures central dopamine activity. Claims by commercial labs to diagnose "dopamine deficiency" from blood or urine tests are not supported by neuroscience.
Dopamine is the primary inhibitor of prolactin secretion. The tuberoinfundibular dopamine pathway sends dopamine from the hypothalamus to the anterior pituitary via the portal blood system, tonically suppressing prolactin release from lactotroph cells. When this dopamine signal is disrupted—by pituitary stalk compression, certain medications (antipsychotics, metoclopramide, which block dopamine D2 receptors), or hypothalamic disease—prolactin rises (hyperprolactinemia). Conversely, dopamine agonists (cabergoline, bromocriptine) are the primary treatment for prolactinomas because they mimic dopamine's inhibitory effect, shrinking most prolactin-secreting tumors dramatically. This dopamine-prolactin axis explains why patients on antipsychotic medications frequently develop elevated prolactin.
Catecholamine testing (including dopamine) is highly sensitive to interference. For accurate results: avoid caffeine, alcohol, nicotine, and strenuous exercise for at least 24 hours before testing. Discontinue interfering medications if medically safe (decongestants, MAO inhibitors, certain antidepressants, levodopa, acetaminophen—discuss with your doctor). For plasma catecholamines, lie supine for 30 minutes before blood draw, as standing increases catecholamines. Avoid stress and pain. For 24-hour urine, follow collection instructions carefully and avoid the same dietary and medication restrictions. Foods rich in catecholamines (bananas, walnuts, avocados, cheese, coffee, chocolate) can falsely elevate urinary levels.

Related Biomarkers

CortisolCortisol5-HTSerotoninPRLProlactin

Want your DA levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.